One fits all hs troponin or more personalized dual markers strategies in the primary diagnostic assessment of patients with suspected acute coronary syndrome?

Möckel, Martin

doi:10.1080/1354750x.2020.1841293

Search citation statements

Order By: Relevance

Paper Sections

Select...

Guideline Highlights For the Ed1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2021

2024

Publication Types

Select...

Article5

Relationship

Self Cite2

Independent3

Authors

Journals

Cited by 5 publications

(2 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In addition, other biomarkers like copeptin may help to solve this dilemma, which is supported by ample evidence [9–13]. The scientific noteworthiness of the ESC guidelines related to other biomarkers than troponin for the initial diagnosis of ACS has been outlined elsewhere in detail [14,15].…”

Section: Guideline Highlights For the Edmentioning

confidence: 99%

Actual guidelines on non-ST-elevation acute coronary syndrome: how do they help in the emergency department?

Möckel¹

2021

European Journal of Emergency Medicine

Self Cite

View full text Add to dashboard Cite

Section: Guideline Highlights For the Edmentioning

confidence: 99%

Actual guidelines on non-ST-elevation acute coronary syndrome: how do they help in the emergency department?

Möckel¹

2021

European Journal of Emergency Medicine

Self Cite

View full text Add to dashboard Cite

“…Literature claiming insufficient evidence for added value of Copeptin and h-FABP in addition to hs-cTn for the initial diagnosis (Adapted from Möckel ref#[82])…”

mentioning

confidence: 99%

Critical appraisal of the 2020 ESC guideline recommendations on diagnosis and risk assessment in patients with suspected non-ST-segment elevation acute coronary syndrome

Giannitsis

Blankenberg²,

Christenson

et al. 2021

Clin Res Cardiol

Self Cite

View full text Add to dashboard Cite

Multiple new recommendations have been introduced in the 2020 ESC guidelines for the management of acute coronary syndromes with a focus on diagnosis, prognosis, and management of patients presenting without persistent ST-segment elevation. Most recommendations are supported by high-quality scientific evidence. The guidelines provide solutions to overcome obstacles presumed to complicate a convenient interpretation of troponin results such as age-, or sex-specific cutoffs, and to give practical advice to overcome delays of laboratory reporting. However, in some areas, scientific support is less well documented or even missing, and other areas are covered rather by expert opinion or subjective recommendations. We aim to provide a critical appraisal on several recommendations, mainly related to the diagnostic and prognostic assessment, highlighting the discrepancies between Guideline recommendations and the existing scientific evidence.

show abstract

The new ESC acute coronary syndrome guideline and its impact in the CPU and emergency department setting

Möckel

2024

Herz

View full text Add to dashboard Cite

One fits all hs troponin or more personalized dual markers strategies in the primary diagnostic assessment of patients with suspected acute coronary syndrome?

Cited by 5 publications

References 17 publications

Actual guidelines on non-ST-elevation acute coronary syndrome: how do they help in the emergency department?

Actual guidelines on non-ST-elevation acute coronary syndrome: how do they help in the emergency department?

Critical appraisal of the 2020 ESC guideline recommendations on diagnosis and risk assessment in patients with suspected non-ST-segment elevation acute coronary syndrome

The new ESC acute coronary syndrome guideline and its impact in the CPU and emergency department setting

Contact Info

Product

Resources

About